Literature DB >> 10394124

Genetic aberrations detected by comparative genomic hybridization in biliary tract cancers.

K Shiraishi1, N Kusano, S Okita, A Oga, K Okita, K Sasaki.   

Abstract

In order to elucidate cytogenetic changes characteristic of biliary tract cancer, we examined the genetic imbalances in 18 biliary tract cancers using comparative genomic hybridization (CGH). The most common sites of increases in copy number, in order of frequency, were 17q (33% of the cases), 5p (28%), 3q (22%), 7p (22%), 8q (22%), and 12p (22%), whereas copy number decreases of 6q (28%), 18q (28%), 4q (22%), 5q (22%), and 9p (22%) were frequent. The average number of chromosomal aberrations was significantly greater in stage IV than in stage III tumors (7.9 vs. 2.2/tumor, p < 0.05). The frequent aberrations detected in this study may be related to the development and/or progression of biliary tract cancers. This is the first report on CGH of biliary tract cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394124     DOI: 10.1159/000011999

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  8 in total

1.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

2.  Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth.

Authors:  E Hidaka; A Yanagisawa; M Seki; T Setoguchi; Y Kato
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Allelic loss of 14q32 in the pathogenesis of gastrointestinal and ampullary malignancies: mapping of the target region to a 17 cM interval.

Authors:  Yuan-Chang Dai; Chung-Liang Ho; Yi-Chang Tsai; Yung-Hsiang Hsu; Yu-Chuang Chang; Hsiao-Sheng Liu; Helen Hai-Wen Chen; Nan-Haw Chow
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-21       Impact factor: 4.553

4.  Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.

Authors:  Jongkonnee Thanasai; Temduang Limpaiboon; Patcharee Jearanaikoon; Vajarabhongsa Bhudhisawasdi; Narong Khuntikeo; Banchob Sripa; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

5.  Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.

Authors:  Chih-Yung Yang; Ju-Yu Tseng; Chian-Feng Chen; Teh-Ying Chou; Hong-Wei Gao; Chia-Ling Hua; Chi-Hung Lin; Jen-Kou Lin; Jeng-Kai Jiang
Journal:  Int J Colorectal Dis       Date:  2015-07-24       Impact factor: 2.571

6.  Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.

Authors:  Shih-Chang Chuang; King-Teh Lee; Kun-Bow Tsai; Pai-Ching Sheen; Eishi Nagai; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 7.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.

Authors:  Alphonse-E Sirica
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

8.  ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.

Authors:  Ruben Jansen; Birte Moehlendick; Christoph Bartenhagen; Csaba Tóth; Nadja Lehwald; Nikolas H Stoecklein; Wolfram T Knoefel; Anja Lachenmayer
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.